HIStalk Sponsor Announcements

Full Version: Announcements
You're currently viewing a stripped down version of our content. View the full version with proper formatting.

Announcements

Threads

  1. RxRevu’s Rapid Growth Enables Patient Affordability and Access to Care (0 Replies)
  2. Netsmart Showcases Interoperability Innovations Driving Care Transitions at HIMSS22 (0 Replies)
  3. FDB Launches FDB Vela – New ePrescribing Network to Deliver Greater Choice and Value (0 Replies)
  4. eVisit and Infermedica Collaborate to Add Triaging API to Virtual Care Platform (0 Replies)
  5. AGS Health Awarded Cybersecurity Transparent Status by KLAS, Censinet (0 Replies)
  6. Sphere’s Integration with Epic MyChart Now Supports Google Pay™ and Apple Pay® (0 Replies)
  7. MEDHOST to Share Digital Patient Experience Vision Introduce New Solutions at HIMSS22 (0 Replies)
  8. Quil launches new ‘Quil Assure’ connected home platform for seniors and caregivers (0 Replies)
  9. 78% of Health System Leaders Say Patient Leakage a Higher Priority After COVID-19 (0 Replies)
  10. FDB to Turn ‘What If’ into ‘What Is’ with Industry-Changing Announcement at HIMSS22 (0 Replies)
  11. ChartSpan Names Christine Hawkins Chief Executive Officer (0 Replies)
  12. Healthwise® Expands Use of FDB’s Meducation® Solution to Enhance Patient Education (0 Replies)
  13. eVisit to Unveil "eAnalyze" Reporting Dashboard at HIMSS22 (0 Replies)
  14. Vocera, now part of Stryker, introduces latest evolution in hands-free communication (0 Replies)
  15. Pivot Point Consulting Recognized Best in KLAS 7th Consecutive Year (0 Replies)
  16. evolvedMD Selects NeuroFlow to Expand, Scale Collaborative Care Program (0 Replies)
  17. ChartSpan to Solve Low RPM Participation with Launch of RPM Enrollment Services (0 Replies)
  18. NeuroFlow partners with Aflac on innovative approach to workplace mental health (0 Replies)
  19. Current Health announces Zoom telehealth integration (0 Replies)
  20. Arcadia to Share Best Practices for Transforming Healthcare at HIMSS22 (0 Replies)